Covered recipient · General Payments record
NIKITHA REDDY
This page merges CMS profile IDs 11553223, 11688141 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2023–2025
$9,474.28
- Reported across 51 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,950.00 | 1 |
| Food and Beverage | $503.76 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LENSAR, Inc. | $2,194.03 | 2 |
| ABBVIE INC. | $117.72 | 6 |
| Bausch & Lomb Americas Inc. | $61.74 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $50.55 | 2 |
| Alcon Vision LLC | $29.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.41 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203804104 | CMS |
| ABBVIE INC. | $21.85 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203804112 | CMS |
| ABBVIE INC. | $19.66 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203804118 | CMS |
| ABBVIE INC. | $22.15 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203804124 | CMS |
| ABBVIE INC. | $18.66 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203804130 | CMS |
| ABBVIE INC. | $16.99 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203804136 | CMS |
| Alcon Vision LLC | $29.72 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207482505 | CMS |
| Bausch & Lomb Americas Inc. | $17.31 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254859867 | CMS |
| Bausch & Lomb Americas Inc. | $19.97 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254859863 | CMS |
| Bausch & Lomb Americas Inc. | $24.46 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254859865 | CMS |
| LENSAR, Inc. | $244.03 | 02/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249336638 | CMS |
| LENSAR, Inc. | $1,950.00 | 03/26/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336874 | CMS |
| Sun Pharmaceutical Industries Inc. | $24.75 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251042739 | CMS |
| Sun Pharmaceutical Industries Inc. | $25.80 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251042741 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
- Merged CMS profile IDs
- 11553223, 11688141
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.